Fasaret

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFasaret

Drug Alias NameAP-300

ClassificationCell and gene therapy > Gene therapy

Mechanisms of ActionImmunomodulatorsSoluble Fas ligand inhibitors

TargetsSoluble Fas ligand

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesApoplogic

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesApoplogic

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A